These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1313234)

  • 21. Differential radioprotection of cultured human diploid fibroblasts and fibrosarcoma cells by WR1065.
    Zhang X; Lai PP; Taylor YC
    Int J Radiat Oncol Biol Phys; 1992; 24(4):713-9. PubMed ID: 1429096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
    Meijer C; de Vries EG; Dam WA; Wilkinson MH; Hollema H; Hoekstra HJ; Mulder NH
    Br J Cancer; 1997; 76(3):290-8. PubMed ID: 9252194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW; Kaltenbach JA; Blakley BW; Burgio DL
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
    Carfagna PF; Chaney SG; Chang J; Holbrook DJ
    Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
    Hettinga JV; Lemstra W; Meijer C; Dam WA; Uges DR; Konings AW; De Vries EG; Kampinga HH
    Br J Cancer; 1997; 75(12):1735-43. PubMed ID: 9192975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
    Fichtinger-Schepman AM; van der Velde-Visser SD; van Dijk-Knijnenburg HC; van Oosterom AT; Baan RA; Berends F
    Cancer Res; 1990 Dec; 50(24):7887-94. PubMed ID: 2253228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
    Montine TJ; Borch RF
    Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E; Groen HJ; Helder MN; de Vries EG; Meijer C
    Biochem Pharmacol; 2002 Jun; 63(11):1989-96. PubMed ID: 12093475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol.
    Nagy B; Dale PJ; Grdina DJ
    Cancer Res; 1986 Mar; 46(3):1132-5. PubMed ID: 3943091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
    Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
    Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of wr2721 (ethiofos) as modulator of Cisplatin-induced neurotoxicity studied at the ultrastructural level in the pond snail lymnaea-stagnalis.
    Muller L; Moorervandelft C; Treskes M; Vermorken J; Vandervijgh W; Boer H
    Int J Oncol; 1993 Apr; 2(4):701-10. PubMed ID: 21573614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA; de Vries EG; Mulder NH
    Br J Cancer; 1990 Jan; 61(1):79-82. PubMed ID: 2153398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective Role of Selected Antioxidant Agents in Preventing Cisplatin-Induced Damage of Human Neurons In Vitro.
    Popović J; Klajn A; Paunesku T; Ma Q; Chen S; Lai B; Stevanović M; Woloschak GE
    Cell Mol Neurobiol; 2019 Jul; 39(5):619-636. PubMed ID: 30874981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro.
    Dempke WC; Shellard SA; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1991 Mar; 12(3):525-8. PubMed ID: 1901253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple method for the inactivation of monofunctionally DNA-bound cis-diamminedichloroplatinum (II).
    Fichtinger-Schepman AM; vd Veer JL; Lohman PH; Reedijk J
    J Inorg Biochem; 1984 Jun; 21(2):103-12. PubMed ID: 6539808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli DNA polymerase I: inherent exonuclease activities differentiate between monofunctional and bifunctional adducts of DNA and cis- or trans-diamminedichloroplatinum(II). An exonuclease investigation of the kinetics of the adduct formation.
    Bernges F; Dörner G; Holler E
    Eur J Biochem; 1990 Aug; 191(3):743-53. PubMed ID: 2167853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
    Yu Z; Eaton JW; Persson HL
    Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar effects of cis-diamminedichloroplatinum(II) and cis-diammine-1,1-cyclobutanedicarboxylatoplatinum(II) on sodium-coupled glucose uptake in renal brush-border membrane vesicles.
    Potdevin S; Courjault-Gautier F; Ripoche P; Toutain HJ
    Arch Toxicol; 1998 Oct; 72(10):663-70. PubMed ID: 9851683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.